Kaiser Health News
As the scientific community scrambles to find a drug that can effectively treat tens of thousands of patients sickened by a new respiratory virus, they are trying some surprising remedies: medicines targeting known killers like HIV, Ebola and malaria.
During the 2020 State of the Union address, President Donald Trump zeroed in on prescription drug prices, arguing that his administration is “taking on the big pharmaceutical companies.”
Polls say health care is consistently at the top of voters’ minds in this election cycle. And President Donald Trump clearly wants to own the issue, often talking about the “wins” stemming from his administration’s policies.
Disclosure this week of an eighth case in the United States of a new viral infection emerging from China — in addition to the first confirmed case of the virus passing from person to person in this country — is fueling public concerns about how easily the deadly virus can spread.
Far more Americans disapprove of President Donald Trump’s handling of several high-profile health care issues than give him positive marks, underscoring the challenge the president faces in claiming health care as a political asset in his reelection bid.
When the first U.S. case of a new coronavirus spreading throughout China was confirmed last week in Washington state, public health workers were well prepared to respond, building on lessons learned during the outbreak of measles that sickened 87 people in the state in 2019.